WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006116661) POLYETHYLENE GLYCOL BASED COMPOSITION FOR TOPICAL TREATMENT OF A CLOSED WOUND WITH THERAPEUTIC PHARMACEUTICALS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/116661    International Application No.:    PCT/US2006/016178
Publication Date: 02.11.2006 International Filing Date: 26.04.2006
IPC:
A61K 9/00 (2006.01), A61K 31/00 (2006.01)
Applicants: AVOCET POLYMER TECHNOLOGIES, INC. [US/US]; 23560 West Main Street, Suite 2, Plainfield, Illinois 60544 (US) (For All Designated States Except US).
MISTRY, Deepak [US/US]; (US) (For US Only).
MEHTA, Anita [IN/US]; (US) (For US Only)
Inventors: MISTRY, Deepak; (US).
MEHTA, Anita; (US)
Agent: KAMAN, C., Noël; BRINKS HOFER GILSON & LIONE, P.O. Box 10087, Chicago, Illinois 60610 (US)
Priority Data:
60/675,940 27.04.2005 US
Title (EN) POLYETHYLENE GLYCOL BASED COMPOSITION FOR TOPICAL TREATMENT OF A CLOSED WOUND WITH THERAPEUTIC PHARMACEUTICALS
(FR) COMPOSITION A BASE DE POLYETHYLENE GLYCOL POUR LE TRAITEMENT TOPIQUE DES PLAIES FERMEES AU MOYEN DE PHARMACEUTIQUES THERAPEUTIQUES
Abstract: front page image
(EN)The present invention relates to compositions, methods and kits for improving the appearance or reducing the size of a closed wound or scar. The composition includes a therapeutically effective amount of at least one non- steroidal anti-inflammatory agent, such as a cyclooxygenase inhibitor and/or NF-kB inhibitor in combination with a polyethylene glycol material. The composition also may include one or more of the following: methyl parabenzene, propyl parabenzene, butylated hydroxy toluene, aloe vera, and vitamin E. The composition further may include an anti-irritant, an anti-prurient, an anti-microbial, and/or a deodorant agent. The composition of the present invention may be administered topically or transdermally.
(FR)Cette invention concerne des compositions, des procédés et des kits servant à améliorer l'aspect ou à réduire la taille d'une plaie fermée ou d'une cicatrice. Cette composition comprend une quantité thérapeutiquement efficace d'au moins un agent anti-inflammatoire non stéroïdien, tel qu'un inhibiteur de cyclo-oxygénase et/ou un inhibiteur de NF-kB, associé à une substance à base de polyéthylène glycol. Cette composition peut également contenir un ou plusieurs des composants suivants: méthyle parabenzène, propyle parabenzène, hydroxy-toluène butylé, aloe vera, et vitamine E. cette composition peut en outre renfermer un agent anti-irritant, un antiprurigineux, un antimicrobien et/ou un déodorisant. Cette composition peut être administrée par voie topique ou transdermique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)